Read + Share
Seo S, Hatano E, Kanai M, Ogawa K, et al. Prospective Observational Study of Sorafenib in Hepatocellular Carcinoma Patients
With Very High Risk of Recurrence After Surgery. Anticancer Res 2022;42:6127-6134.
PMID: 36456121
|
 |
|
Seo S, Hatano E, Kanai M, Ogawa K, et al. Prospective Observational Study of Sorafenib in Hepatocellular Carcinoma Patients
With Very High Risk of Recurrence After Surgery. Anticancer Res 2022;42:6127-6134.
PMID: 36456121
|
|
|
|